Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Fertil Steril ; 116(6): 1568-1577, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34465452

RESUMO

OBJECTIVE: To compare the effectiveness of two different treatment regimens of dydrogesterone in the management of endometriosis-related chronic pelvic pain. DESIGN: Observational, prospective cohort study over six months. SETTING: Twenty gynecology clinics in the Russian Federation. PATIENT(S): Three hundred fifty women from 18 to 45 years of age with endometriosis and chronic pelvic pain with or without dysmenorrhea. INTERVENTION(S): Dydrogesterone 10 mg 2 or 3 times daily, either between the 5th and 25th days of the menstrual cycle (prolonged cyclical treatment regimen) or continuously (continuous treatment regimen). For all patients, the data cutoff was at six months of treatment. MAIN OUTCOME MEASURE(S): Intensity of chronic pelvic pain on the 11-point numerical rating scale (after 6 months). RESULT(S): A marked reduction in chronic pelvic pain was observed with both the prolonged cyclical and continuous treatment regimens (mean ± standard deviation change from baseline -3.3 ± 2.2 and -3.0 ± 2.2, respectively), with no significant difference between the two groups. With both regimens, patients experienced significant improvements in the intensity of chronic pelvic pain, number of days in which analgesics were required, severity of dysmenorrhea, sexual well-being, and health-related quality-of-life parameters. A favorable safety profile of dydrogesterone was confirmed, and no serious adverse drug reactions were reported during the study. CONCLUSION(S): Prolonged cyclical and continuous treatment regimens of dydrogesterone therapy both demonstrated a pronounced and similar reduction in the severity of chronic pelvic pain and dysmenorrhea and led to marked improvements in all study parameters related to quality of life and sexual well-being. REGISTRATION NUMBER: NCT03690765.


Assuntos
Dor Crônica/tratamento farmacológico , Didrogesterona/administração & dosagem , Endometriose/tratamento farmacológico , Dor Pélvica/tratamento farmacológico , Progestinas/administração & dosagem , Adolescente , Adulto , Dor Crônica/diagnóstico , Esquema de Medicação , Dismenorreia/diagnóstico , Dismenorreia/tratamento farmacológico , Dismenorreia/epidemiologia , Endometriose/diagnóstico , Endometriose/epidemiologia , Feminino , Humanos , Pessoa de Meia-Idade , Dor Pélvica/diagnóstico , Dor Pélvica/epidemiologia , Estudos Prospectivos , Resultado do Tratamento , Adulto Jovem
2.
Sci Rep ; 7(1): 2546, 2017 05 31.
Artigo em Inglês | MEDLINE | ID: mdl-28566741

RESUMO

Obtaining fast screening information on molecular composition of a tissue sample is of great importance for a disease biomarkers search and for online surgery control. In this study, high resolution mass spectrometry analysis of eutopic and ectopic endometrium tissues (90 samples) is done using direct tissue spray mass spectrometry in both positive and negative ion modes. The most abundant peaks in the both ion modes are those corresponding to lipids. Species of three lipid classes are observed, phosphatidylcholines (PC), sphingomyelins (SM) and phosphoethanolamines (PE). Direct tissue analysis gives mainly information on PC and SM lipids (29 species) in positive ion mode and PC, SM and PE lipids (50 species) in negative ion mode which gives complementary data for endometriosis foci differentiation. The biggest differences were found for phospholipids with polyunsaturated acyls and alkils. Although, tissue spray shows itself as appropriate tool for tissue investigation, caution should be paid to the interpretation of mass spectra because of their higher complexity with more possible adducts formation and multiple interferences must be taken into account. The present work extends the application of direct tissue analysis for the rapid differentiation between endometriotic tissues of different foci.


Assuntos
Endometriose/diagnóstico , Cistos Ovarianos/diagnóstico , Fosfatidilcolinas/isolamento & purificação , Fosfatidiletanolaminas/isolamento & purificação , Esfingomielinas/isolamento & purificação , Adulto , Estudos de Casos e Controles , Diagnóstico Diferencial , Endometriose/metabolismo , Endometriose/patologia , Endometriose/cirurgia , Endométrio/metabolismo , Endométrio/patologia , Endométrio/cirurgia , Feminino , Humanos , Metabolismo dos Lipídeos , Metaboloma , Pessoa de Meia-Idade , Cistos Ovarianos/metabolismo , Cistos Ovarianos/patologia , Cistos Ovarianos/cirurgia , Fosfatidilcolinas/classificação , Fosfatidilcolinas/metabolismo , Fosfatidiletanolaminas/classificação , Fosfatidiletanolaminas/metabolismo , Espectrometria de Massas por Ionização por Electrospray , Esfingomielinas/classificação , Esfingomielinas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA